| 1 | Flynn James E
Deerfield Mgmt HIF L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Healthcare Innovations Fund L.P.
Deerfield Mgmt L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
DEERFIELD PARTNERS L.P.
*Possible Member of 10% Group
10% Owner | 2024-02-01 17:29:56 | 2,613,012
0 | 2,613,012 | Form 13G |
| 2 | Sanderling Venture Partners VI Co Investment Fund LP
Sanderling Ventures Management VI
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling Venture Partners VI LP
Sanderling VI Limited Partnership
Sanderling Ventures VII L.P.
Sanderling Ventures VII (Canada) L.P.
Sanderling Ventures VII Annex Fund L.P.
Sanderling Ventures Management VII
10% Owner | 2024-11-26 06:03:55 | 2,550,550
0 | 2,550,550 | Form 13D |
| 3 | Valence Investments SPV IV LLC
Valence Investments SPV V LLC
Valence Investments SPV VI LLC
10% Owner | 2024-11-06 16:17:55 | 1,217,678
0 | 1,217,678 | Form 13D |
| 4 | Keyoung Hansoo Michael
Director | 2020-09-29 16:40:20 | 0
1,133,596 | 1,133,596 | Form 4 |
| 5 | Roberts Eric W
CHIEF BUSINESS OFFICER
10% Owner | 2025-07-23 11:55:44 | 164,706
849,204 | 1,013,910 | Form 4 |
| 6 | Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
10% Owner | 2025-07-21 14:02:43 | 130,926
743,826 | 874,752 | Form 4 |
| 7 | WILSON ROBERT N
Director | 2025-07-18 14:42:42 | 422,029
0 | 422,029 | Form 4 |
| 8 | ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
10% Owner | 2024-02-05 16:48:48 | 297,380
0 | 297,380 | Form 13D |
| 9 | Hebbar Sudarshan
Chief Medical Officer | 2025-06-26 18:31:33 | 83,300
0 | 83,300 | Form 4 |
| 10 | Bardin Stephen
Chief Financial Officer | 2025-06-26 18:30:22 | 60,000
3,000 | 63,000 | Form 4 |
| 11 | Shaw Allan
Director | 2025-06-26 18:21:28 | 54,844
0 | 54,844 | Form 4 |
| 12 | Dunn Michael J.
President and COO | 2025-06-26 18:27:25 | 47,125
0 | 47,125 | Form 4 |
| 13 | MIDDLETON FRED A
Director
10% Owner | 2025-06-26 18:18:33 | 46,249
0 | 46,249 | Form 4 |
| 14 | Guerard Frederic
Director | 2025-06-26 18:25:13 | 40,000
0 | 40,000 | Form 4 |
| 15 | Glicklich Alan
Director | 2025-06-26 18:23:49 | 39,166
0 | 39,166 | Form 4 |
| 16 | BREUIL ROBERT S
Chief Financial Officer | 2023-03-27 19:56:09 | 35,326
0 | 35,326 | Form 4 |
| 17 | Salain Daniel
CTOO | 2020-12-10 17:10:59 | 35,000
0 | 35,000 | Form 4 |
| 18 | Zamiri Parisa
Chief Medical Officer | 2023-03-27 19:59:47 | 28,982
0 | 28,982 | Form 4 |
| 19 | Stauderman Kenneth A.
Chief Scientific Officer | 2025-07-29 16:52:29 | 12,944
0 | 12,944 | Form 4 |
| 20 | Cagle Gerald D.
Director | 2021-06-04 18:37:44 | 12,500
0 | 12,500 | Form 4 |
| 21 | BJERKHOLT ERIC
Director | 2024-08-28 19:14:14 | 10,000
0 | 10,000 | Form 4 |
| 22 | Geffken Daniel E.
Interim CFO | 2024-05-20 19:47:02 | 0
10,000 | 10,000 | Form 4 |
| 23 | SHAFFER CHRISTY L
Director | 2023-03-27 19:59:08 | 1,429
0 | 1,429 | Form 4 |
| 24 | Sauer Dirk
Director | 2023-03-27 19:58:21 | 1,429
0 | 1,429 | Form 4 |
| 25 | EASTLAND JULIA MARIE
Director | 2023-03-27 19:57:01 | 1,429
0 | 1,429 | Form 4 |
| 26 | ACKERMANN CHRISTINA
Director | 2023-03-27 19:54:44 | 1,429
0 | 1,429 | Form 4 |
| 27 | Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Blackstone Clarus III L.L.C.
Blackstone Holdings II L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Group Inc
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner | 2022-02-11 06:40:04 | 0
0 | 0 | Form 13G |